Biomarker Discovery & Validation
News on biomarker discovery and validation for research and diagnostic use in genetics, genomics, and molecular diagnostics.
Hemogenyx to Use FLT3 Assay to Identify AML Patients for CAR T-Cell Trial
The firm expects to launch its Phase I trial of HEMO-CAR-T in FLT3-expressing AML patients at MD Anderson Cancer Center imminently.
Flagship Pioneering, Quotient Therapeutics Team up for Pfizer Drug Discovery Partnership
Under the agreement, the companies aim to discover new drug targets in cardiovascular and renal diseases using Quotient's cell phenotyping and genomic sequencing platform.
Metabolon, SERA Partner on Research Into Metabolomic Biomarkers for Rheumatoid Arthritis
The project will combine Metabolon's metabolomics platform with SERA's patient samples to study molecular mechanisms of RA development and progression.
Foundation for the NIH Launches $21M Research Project to Identify Parkinson's Disease Biomarkers
The new public-private partnership is funded by organizations including the NIH, FDA, Michael J. Fox Foundation, C2N Diagnostics, and Sanofi.
Foundation for the NIH Consortium Launches Multiple Myeloma Biomarker Discovery Project
In the three-year, $4.5 million effort, the foundation aims to accelerate development of biomarkers that identify patients at high risk for multiple myeloma.